A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
about
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesRandomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).Advances in the management of squamous cell carcinoma of the head and neck.Helical tomotherapy in head and neck cancer: a European single-center experience.Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 studyInduction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes.Sequential chemoradiation in locally advanced head and neck cancer after induction chemotherapy: an induction chemotherapy schedule more suited to a limited resource settingThe Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach.Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation).Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservationChemotherapy: United Kingdom National Multidisciplinary GuidelinesOutcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients.Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers.Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.Pharmacotherapy of head and neck cancer.Systemic therapy in the curative treatment of head-and-neck squamous cell cancer: Cancer Care Ontario clinical practice guidelineUnknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites.Safety of drug treatments for head and neck cancer.Induction chemotherapy for head and neck cancer: is there still a role?ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic reviewSurvival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.Outcome of Neoadjuvant Chemotherapy on Local Recurrence and Distant Metastasis of Oral Squamous Cell Carcinoma: A Retrospective Study.Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety.Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study.Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or AssistanceRacial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
P2860
Q26767046-2DC702BD-771D-4AF4-A345-E56C8C71B7DFQ33420293-57BF4FFF-C2B1-4794-A805-19BED0198D5BQ33720431-B364A817-ACF7-41A2-9EAF-B9506B8467F6Q35151101-E4E08CB0-B7DB-4993-B2DF-16449145933BQ35602143-59A41ACD-12FF-4D3C-B4C2-6114460DABF3Q35652246-DD11EB71-154A-457F-9202-BE0D51DEF9D6Q35677705-87351A7A-8451-41CC-8147-29218408B217Q35717521-FBA937F6-BA43-46C7-92BC-1CC3D76B7F97Q35845864-E07F1096-AD2E-4810-952D-C3DE399C8834Q36051701-E6D972F6-2A24-477F-AED0-8360AE10145FQ36341166-4CF028DA-172C-440D-850D-1AB051EFA9CCQ36378279-FCAFEEC7-9083-48C9-95E8-ADAB63C34BB3Q36452263-A39F5F21-5509-433C-B3E2-EEAB506D6F5EQ36587228-AA8E0730-C4EF-4801-823D-99A1C0B38E45Q36864470-13708545-CCF8-4054-B7F0-14CC649676AFQ36919595-F9CEB09C-0031-4638-B653-A66F27C6020EQ37206229-1D00582A-993A-4076-A6F9-700354451B1AQ37392967-E624BD93-BF67-4D45-B70B-5352A6A0395CQ37612343-5801DF9A-02B1-48A7-BA60-7DF1F9B4EE5AQ37737013-423233A9-3090-4B75-A6BC-53ADD3D93B7CQ38195721-ADC2D656-965B-4A58-B588-18802C60BF26Q38285974-C24BAB06-9E4F-4D64-9C71-A2C7B08477FAQ38419487-30A1092D-06F3-4F49-819C-B4E488AF46EBQ38619293-540B931E-6BE0-4B8F-9FB4-6B422ABBE642Q38685473-4AC182F3-9D96-42A0-9486-E9067AD676C3Q38735944-432982F6-6921-4989-8DDA-A362A53E7FA8Q38760427-BF32E52C-5B7A-45D0-952D-7530FA02AEA5Q38809582-D14C41DD-B79B-49F5-B376-0BA4F8EE33ABQ38811999-43968CC1-70DC-4DAD-BE40-8F61B7C70D66Q38850017-F2BEAF5D-B20D-406E-B155-08D67A29C46EQ38855117-56F9DF90-D2E8-4627-857E-4BF0052037B1Q38903477-999389E0-15D5-42CC-A5F8-1238535E57F8Q39370399-80D2CB2C-9FAF-40CA-9A3F-37C0A6BFE657Q39415046-341D5C2A-698E-4919-BDBC-83CC612E12F3Q40197080-B2CE9820-4F63-4207-B3C0-A66405EDA56DQ40374903-236C66FA-4853-49ED-8C76-913FD5EC3042Q40600518-3DF4E4D0-5694-432E-A360-69A80B947590Q41208260-9C71368B-24CD-4433-984D-F77B014C2927Q41396937-67E07C4E-EC58-4011-8EC7-C426FFE062B7Q41646543-228BA305-56FD-44C1-B2FA-E9D41556E9CE
P2860
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A randomized phase III trial c ...... sectable head and neck cancer.
@en
A randomized phase III trial c ...... sectable head and neck cancer.
@nl
type
label
A randomized phase III trial c ...... sectable head and neck cancer.
@en
A randomized phase III trial c ...... sectable head and neck cancer.
@nl
prefLabel
A randomized phase III trial c ...... sectable head and neck cancer.
@en
A randomized phase III trial c ...... sectable head and neck cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
A randomized phase III trial c ...... sectable head and neck cancer.
@en
P2093
A Berrocal
A Irigoyen
A López-Pousa
C García-Girón
J A Brandariz Castelo
J J Cruz-Hernández
J Martínez-Trufero
P2860
P304
P356
10.1093/ANNONC/MDT461
P577
2013-11-19T00:00:00Z